Triathlon® Posteriorly Stabilized (PS) Total Knee System - Outcomes Study

Stryker Orthopaedics409 enrolled

Overview

The purpose of this study is to evaluate the clinical outcomes (range of motion, pain, function, radiographic stability, and health related quality of life) of patients receiving the Triathlon® Posterior Stabilized (PS) Total Knee System. These outcomes will be evaluated using pre-operative scores and comparing them to post-operative scores in addition to being compared with cases who received the Scorpio® PS implant.

The Triathlon® Posteriorly Stabilized (PS) Total Knee System components are for use in cemented total knee arthroplasty for painful, disabling joint disease of the knee resulting from non-inflammatory degenerative joint disease (including osteoarthritis, traumatic arthritis or avascular necrosis) or rheumatoid arthritis (excluded from this study according to protocol). The components are designed to improve range of motion (ROM) and stability. This study serves to demonstrate that subjects have reduced pain, increased ROM and improved stability following implantation with the Triathlon® PS Total Knee System.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

409

Conditions

Arthroplasty, Replacement, Knee

Interventions

Triathlon® PS Total Knee SystemDEVICE

Triathlon® PS Total Knee system

Eligibility

Sex: ALLMin age: 21 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. The subject is a male or non-pregnant female 21-80 years of age at the time of enrollment. 2. The subject requires a primary cemented total knee replacement. 3. The subject has a diagnosis of osteoarthritis (OA), traumatic arthritis (TA), or avascular necrosis (AVN). 4. The subject has intact collateral ligaments. 5. The subject has signed the IRB approved, study specific Informed Patient Consent Form. 6. The subject is willing and able to comply with postoperative scheduled clinical and radiographic evaluations and rehabilitation. Exclusion Criteria: 1. The subject has inflammatory arthritis. 2. The subject is morbidly obese, BMI \> 40. 3. The subject has a history of total or unicompartmental reconstruction of the affected joint. 4. The subject has had a high tibial osteotomy or femoral osteotomy. 5. The subject has a neuromuscular or neurosensory deficiency that would limit the ability to assess the performance of the device. 6. The subject has a systemic or metabolic disorder leading to progressive bone deterioration. 7. The subject is immunologically suppressed, or receiving chronic steroids (\>30 days duration). 8. The subject's bone stock is compromised by disease or infection and cannot provide adequate support and/or fixation to the prosthesis. 9. The subject has had a knee fusion at the affected joint. 10. The subject has an active or suspected latent infection in or about the knee joint. 11. The subject is a prisoner.

Locations (11)

Hughston Clinic PA

Columbus, Georgia, United States

Ireland Hip and Knee Surgery

Indianapolis, Indiana, United States

New England Baptist Hospital

Boston, Massachusetts, United States

Outcomes

Primary Outcomes

Range of Motion

The primary outcome of this study is to compare active range of motion values for the Triathlon PS Total Knee System.

Time frame: 2 years

Secondary Outcomes

Patient Outcome Knee Society Score

The Knee Society Scores (KSS) at 1, 2, and 5-year visits will be compared. Additionally, comparison of scores at each post-surgery visit with baseline will be tested to see if any improvement is seen at each time point. The Knee Society Clinical Rating System is comprised of two distinct sub-scores: one for pain, ROM and joint stability, and one for functional parameters. Sub-scores range from a potential minimum score of 0 to a maximum score of 100 points. Although the specific scores are not distinguished as "excellent," "good," "fair," or "poor," a higher value represents a better outcome.

Time frame: 1,2 and 5 years

Patient Outcome SF-36

The SF-36 score at 1, 2, 3, 4 and 5-year visits will be compared at each post-surgery visit with baseline to see if any improvement is seen for each time point.The SF-36 includes a physical component and a mental component and is completed by the participant. Physical component and mental component scores were calculated on a scale ranging from 0 to 100. Low values represented a poor health state and high values represented a good health state.

Time frame: 1,2,3,4 and 5 years

Patient Outcome WOMAC

The Western Ontario and McMaster Osteoarthritis Index (WOMAC) scores at 1, 2, 3, 4 and 5-year visits will be compared between groups, when data is available. Additionally, comparison of scores at each post-surgery visit with baseline will be tested to see if any improvement is seen for each time point. The WOMAC collects information specific to osteoarthritis outcomes. The questionnaire uses a visual analog scale for pain, measuring factors of general pain, stiffness, and physical findings. Pain is scored from 0 to 100 for each set of factors, with 0 indicating no pain and 100 indicating extreme pain. Total WOMAC scores range from 0 to 300. Lower values represent better outcomes. Data for the WOMAC is only available at the 5 year interval due to typographical errors noted on earlier interval forms rendering them invalid for comparison.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.